Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer
NCT02214602
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
240
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma of Urinary Bladder, Superficial
Interventions
DRUG:
Epirubicin
Sponsor
Mansoura University